Gene Expression Profiling
"Gene Expression Profiling" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The determination of the pattern of genes expressed at the level of GENETIC TRANSCRIPTION, under specific circumstances or in a specific cell.
| Descriptor ID |
D020869
|
| MeSH Number(s) |
E05.393.332
|
| Concept/Terms |
Gene Expression Profiling- Gene Expression Profiling
- Gene Expression Profilings
- Profiling, Gene Expression
- Profilings, Gene Expression
- Transcriptome Profiling
- Profiling, Transcriptome
- Profilings, Transcriptome
- Transcriptome Profilings
- Transcript Expression Analysis
- Analyses, Transcript Expression
- Analysis, Transcript Expression
- Transcript Expression Analyses
- Transcriptome Analysis
- Analyses, Transcriptome
- Analysis, Transcriptome
- Transcriptome Analyses
- Gene Expression Monitoring
- Gene Expression Monitorings
- Monitoring, Gene Expression
- Monitorings, Gene Expression
- Gene Expression Pattern Analysis
mRNA Differential Display- mRNA Differential Display
- Differential Display, mRNA
- Differential Displays, mRNA
- Display, mRNA Differential
- Displays, mRNA Differential
- mRNA Differential Displays
|
Below are MeSH descriptors whose meaning is more general than "Gene Expression Profiling".
Below are MeSH descriptors whose meaning is more specific than "Gene Expression Profiling".
This graph shows the total number of publications written about "Gene Expression Profiling" by people in this website by year, and whether "Gene Expression Profiling" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 4 | 5 | 9 |
| 2001 | 4 | 6 | 10 |
| 2002 | 5 | 8 | 13 |
| 2003 | 15 | 15 | 30 |
| 2004 | 14 | 22 | 36 |
| 2005 | 11 | 22 | 33 |
| 2006 | 25 | 33 | 58 |
| 2007 | 21 | 34 | 55 |
| 2008 | 18 | 35 | 53 |
| 2009 | 23 | 50 | 73 |
| 2010 | 17 | 61 | 78 |
| 2011 | 26 | 63 | 89 |
| 2012 | 18 | 41 | 59 |
| 2013 | 15 | 59 | 74 |
| 2014 | 11 | 43 | 54 |
| 2015 | 15 | 58 | 73 |
| 2016 | 17 | 47 | 64 |
| 2017 | 21 | 63 | 84 |
| 2018 | 15 | 55 | 70 |
| 2019 | 15 | 48 | 63 |
| 2020 | 17 | 35 | 52 |
| 2021 | 10 | 42 | 52 |
| 2022 | 4 | 15 | 19 |
| 2023 | 4 | 22 | 26 |
| 2024 | 7 | 39 | 46 |
| 2025 | 4 | 25 | 29 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gene Expression Profiling" by people in Profiles.
-
Single cell sequencing analysis of respiratory syncytial virus-infected pediatric and adult human nose organoids reveals age differences, proliferative diversity and identifies novel cellular tropism. J Infect. 2025 Oct; 91(4):106617.
-
Characterization of the tumor immune microenvironment in pregnancy-associated breast cancer through multiplex immunohistochemistry and transcriptome analyses. Breast Cancer Res. 2025 Aug 26; 27(1):154.
-
Transcriptomic resource and hormonal profiling of the smut fungus, Ustilago esculenta, coexisting with Zizania latifolia and forming Makomotake. Biosci Biotechnol Biochem. 2025 Aug 23; 89(9):1293-1301.
-
Exposure-inducible genes may contribute to missingness in RNAseq-based gene expression analyses. Sci Rep. 2025 Aug 22; 15(1):30889.
-
Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma. Clin Cancer Res. 2025 Aug 01; 31(15):3249-3258.
-
Unveiling spatial heterogeneity in medulloblastoma: A multi-omics analysis of cellular state and geographical organization. Neuro Oncol. 2025 Jul 30; 27(6):1611-1627.
-
Gene expression in tumor and adjacent normal tissues in lung adenocarcinoma subtypes. BMC Cancer. 2025 Jul 14; 25(1):1169.
-
RNA Sequence Analysis in Macrophages Infected With Trypanosoma cruzi: Focus on TLR2 and TLR7, Iron Metabolism, and Extracellular Matrix Biosynthesis. J Infect Dis. 2025 Jul 11; 231(6):e1102-e1113.
-
Gene context drift identifies drug targets to mitigate cancer treatment resistance. Cancer Cell. 2025 Sep 08; 43(9):1608-1621.e9.
-
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma. Cancer Biomark. 2025 Jun; 42(6):18758592251344936.